Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06378957
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-23
First Post:
2024-04-18
Brief Title:
Behavioral Pharmacology of Orally Administered THC and D-limonene
Sponsor:
Johns Hopkins University
Organization:
Johns Hopkins University
Study Overview
Official Title:
Behavioral Pharmacology of Orally Administered THC and D-limonene
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The current clinical trial will investigate the effects of orally administered d-limonene limonene delta-9-tetrahydrocannabinol THC and the combination in healthy adult volunteers
Detailed Description:
The current clinical trial will investigate the interaction of orally administered d-limonene limonene and delta-9-tetrahydrocannabinol THC Limonene is a flavorfragrance component common to many plants including cannabis The investigators have previously demonstrated that vaporized limonene can impact the acute effects of THC The purpose of this study is to examine whether orally administered limonene modulates the acute effects of orally co-administered THC in a manner similar to when these substances are inhaled A controlled laboratory study will be completed at Johns Hopkins evaluating placebo THC alone and four ascending doses of d-limonene in combination with THC Participants will be healthy adults with experience using cannabis A total of 6 outpatient drug administration sessions will be conducted for each evaluable participant The investigators will recruit study volunteers until 20 participants complete the protocol
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None